Financhill
Back

Guardant Health 10K Form

Sell
43

GH
Guardant Health

Last Price:
18.12
Seasonality Move:
13.54%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive GH News And Ratings

See the #1 stock for the next 7 days that we like better than GH

GH Financial Statistics

Sales & Book Value

Annual Sales: $563.95M
Cash Flow: $-82.81M
Price / Cash Flow: 0
Annual Sales: $1.30
Price / Book: 14.32

Profitability

EPS (TTM): -4.28000
Net Income (TTM): $-479.45M
Gross Margin: $336.9M
Return on Equity: -344.76%
Return on Assets: -28.05%

Guardant Health Earnings Forecast

Key Guardant Health Financial Ratios

  • The Gross Profit Margin over the past 8 years for GH is 59.74%.
  • The Selling, General & Administrative Expenses for GH have been equal to 79.98% of Gross Profit Margin.
  • The Research & Development expenses have been 65.11% of Revenue.
  • The Interest Expense is -0.54% of Operating Income.
  • The Net Earning history of GH is -85.02% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 2 years.

Guardant Health Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Current Symbol: GH
CUSIP: 40131M
Website: guardanthealth.com

Debt

Debt-to-Equity Ratio: 7.18
Current Ratio: 6.54
Quick Ratio: 6.11

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

GH Technical Analysis vs Fundamental Analysis

Sell
43
Guardant Health (GH) is a Sell

Is Guardant Health a Buy or a Sell?

  • Guardant Health stock is rated a Sell
    The current Guardant Health [GH] share price is $18.67. The Score for GH is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.